The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPathfinder Minerals Regulatory News (PFP)

  • This share is currently suspended. It was suspended at a price of 0.275

Share Price Information for Pathfinder Minerals (PFP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.275
PFP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising

3 Apr 2020 11:37

RNS Number : 7570I
Pathfinder Minerals Plc
03 April 2020
 

3 April 2020

Pathfinder Minerals Plc

 

("Pathfinder" or the "Company")

 

Fundraising

 

Pathfinder is pleased to announce the conditional issue of a £175,000 convertible loan note.

 

Issue of convertible loan notes instrument (the "Instrument")

 

Subject to shareholder approval at a General Meeting to be convened (the "GM"), the Company has entered into binding agreements for the issue of 175,000 convertible loans notes (the "CLNs"), raising, in aggregate, £175,000 (the "Principal Amount") pursuant to subscriptions with a Director of the Company and certain existing and new investors (the "Subscribers").

The key terms of the Instrument are as follows:

Six month term from the date of the first tranche being received by the Company (see following bullet point) which is expected to be 1 June 2020, subject to shareholder approval, with a 16% coupon on an annualised basis.

Principal Amount to be drawn equally over five monthly tranches and interest will be payable only on funds provided to the Company.

In total, at the end of the six month term, the CLNs will have an aggregate principal plus accrued interest balance of £184,359.

Interest will be payable on the maturity date either in cash or in new Ordinary Shares at the Company's election at a price of 0.6p per share. Should an equity raise be conducted prior to the end of the six month term then the interest, if paid in Ordinary Shares, will be payable at the subscription price of the equity raise, if below 0.6p per share.

29,166,666 warrants will be issued to the Subscribers (the "Warrants"). Each Warrant will have an exercise price of 0.6p and be convertible into one Ordinary Share. The Warrants, if not exercised, will expire after two years from the date of the forthcoming GM. Assuming shareholders approve the resolutions at the GM, should an equity fundraising take place prior to 30 April 2021, then the exercise price of any unexercised Warrants will re-strike to the price associated with such equity fundraise, if below 0.6p per share.

A mandatory exercise of the Warrants will be triggered should the Company's share price exceed 1.5p for a period of more than 20 trading days with a volume traded of at least 50 million shares within that period.

On the maturity date, the Company has the right to force the conversion of all or some of the Principal Amount and accrued interest into new Ordinary Shares should the Company determine, acting reasonably, that that it does not have sufficient cash to fund its working capital requirements and to satisfy the repayment of the Principal Amount. Such a conversion would take place at 90% of the 10 day volume weighted average price at the close of trading on the day prior to forced conversion.

 

The Company is required to hold the GM to approve the disapplication of pre-emption rights in relation to, inter alia, the issue of the CLNs and the Warrants. The provision of the Principal Amount to the Company is conditional on the passing of certain resolutions at the GM and shareholders will be strongly encouraged to vote in favour of the resolutions.

 

Related party transaction

 

John Taylor, Chief Executive Officer of Pathfinder, has agreed to subscribe for £25,000 of the CLNs. Such subscription by John Taylor, as a director of the Company, is considered to be a related party transaction pursuant to Rule 13 of the AIM Rules for Companies. The directors of the Company, other than John Taylor, consider, having consulted with the Company's Nominated Adviser, Strand Hanson Limited, that the terms of his subscription are fair and reasonable in so far as the Company's shareholders are concerned.

 

Shareholder approval at the GM

 

The issuance of the CLNs and the Warrants are conditional upon the approval of shareholders of the Company at the GM. In addition, the Board will be seeking further authorities to issue new Ordinary Shares on an ongoing basis. There will be certain conditionality attached to the passing of the resolutions, which will be explained in the requisite circular and Notice of Meeting, which is currently being prepared and is expected to be published shortly.

 

John Taylor, Chief Executive Officer of Pathfinder, commented:

 

"The participation of new and existing investors in this convertible debt financing is a vote of confidence in the strategy that the Board has been pursuing. Despite the ongoing global challenges, it is encouraging that the Company has been able to raise further financing in the current climate, with the potential equity conversion being at a premium to the current share price. The flexibility provided by this short term debt financing and the convertible element associated with it, gives the Company freedom to continue to pursue the recovery of an interest in Mining Licence 4623C."

 

Enquiries:

Pathfinder Minerals Plc

John Taylor, Chief Executive Officer

Tel. +44 (0)20 3440 7775

 

Strand Hanson Limited (Nominated & Financial Adviser and Broker)

James Spinney / Ritchie Balmer / Jack Botros

Tel. +44 (0)20 7409 3494

 

Vigo Communications (Public Relations)

Ben Simons / Simon Woods

Tel. +44 (0)20 7390 0234

Email. pathfinderminerals@vigocomms.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEUOORRRSUSRAR
Date   Source Headline
6th Jun 20223:52 pmRNSNotice of AGM
6th Jun 20223:50 pmRNSFinal Results for the Year Ended 31 December 2021
6th May 20223:19 pmRNSExtension of Certain Share Options and Warrants
6th May 20223:10 pmRNSIssue of Equity and TVR
12th Apr 20227:00 amRNSCompany Strategy Update
10th Dec 202111:05 amRNSSecond Price Monitoring Extn
10th Dec 202111:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
4th Oct 20214:30 pmRNSGrant of Share Options
14th Sep 20217:00 amRNSHalf-year Results
19th Jul 20213:13 pmRNSChange of Registered Office
30th Jun 202111:47 amRNSResult of Annual General Meeting
29th Jun 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
24th Jun 202111:00 amRNSGrant of Share Options
9th Jun 202110:38 amRNSGrant of Share Options
7th Jun 20217:02 amRNSChange of Adviser
7th Jun 20217:01 amRNSNotice of AGM
7th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSHolding(s) in Company
25th May 20217:00 amRNSDirector Appointment
21st May 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
12th May 20215:40 pmRNSHolding(s) in Company
12th May 202112:33 pmRNSHolding(s) in Company
4th May 20213:40 pmRNSIssue of Equity and Total Voting Rights
12th Apr 20217:00 amRNSUpdate re Bilateral Investment Treaty Claim
1st Apr 20215:58 pmRNSGrant of Share Options
1st Apr 20215:57 pmRNSHolding(s) in Company
29th Mar 20212:07 pmRNSResult of General Meeting - Replacement
29th Mar 202112:29 pmRNSResult of General Meeting
17th Mar 20217:00 amRNSDirectorate Change
10th Mar 20217:00 amRNSNotice of General Meeting
1st Mar 202110:59 amRNSChange of Auditor
19th Feb 20213:34 pmRNSStrategy Update, Placing, CLN Amendment & TVR
25th Jan 202111:05 amRNSSecond Price Monitoring Extn
25th Jan 202111:00 amRNSPrice Monitoring Extension
20th Jan 202112:22 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
6th Jan 20212:01 pmRNSPrice Monitoring Extension
29th Dec 20204:32 pmRNSDirector/PDMR Shareholding
16th Dec 20203:32 pmRNSBilateral Investment Treaty Claim – Legal Opinion
11th Dec 20207:00 amRNSUpdate Re Mining Licence
30th Nov 20207:00 amRNSRecovery of Costs Awards
18th Nov 20205:15 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSCLN Conversion and Final Settlement
5th Nov 202011:32 amRNSCLN Maturity Date
4th Nov 20207:00 amRNSIssue of Warrants
2nd Nov 20207:00 amRNSCompany Strategy Update
30th Oct 20207:00 amRNSHalf-year Report
29th Oct 20207:00 amRNSChange of Admission Date
22nd Oct 20207:05 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.